Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AGEN-1777 by Bristol-Myers Squibb for Colon Cancer: Likelihood of Approval
AGEN-1777 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Colon Cancer. According to GlobalData, Phase...